Facebook
Twitter
LinkedIn
ForwardOral Food Challenge Series
The oral food challenge (OFC) serves as an important tool for the practicing allergist caring for patients of all ages with concern for food allergy, and it is the gold standard to diagnose food allergy and evaluate for the development of tolerance. This module reviews the actions, environment and staff required to safely conduct an OFC in the office setting in accordance with Conducting an Oral Food Challenge: An Update to the 2009 Adverse Reactions to Foods Committee Work Group Report (2020).
This series significantly modified the 2023 online course, "Conducting Physician-Supervised Oral Food Challenges." Learners will benefit from updated written content, videos and case scenarios in this new series.
Target Audience
- Allergist/immunologists
- Fellows-in-Training
- Nurses and Nurse Practitioners
- Physician Assistants and Other Allied Health Professionals
Learning Objectives
Upon completion of all courses in this three part series, learners will be able to:
Identify learning requirements unique to staff members' specific roles in performing OFCs.
Identify equipment and clinical setting requirements as well as staff, resources and training that are necessary when preparing to conduct an OFC.
Outline key concepts to include when educating patients and families before and after the procedure.
Summarize the essential elements of the OFC procedure.
Demonstrate appropriate decision-making skills at critical points in OFC case scenarios.
The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were mitigated by the planners, faculty and reviewers prior to their participation in the development of this activity.
Faculty
Lead Author:
Kim E. Mudd, RN MSN
Johns Hopkins University
Relevant relationships: None
Contributing Authors:
Amy CaJacob, MD
University of Alabama at Birmingham
Relevant relationships: None
Derek Chu, MD
McMaster University
Relevant relationships: None
Maria Crain, RN MA CPNP
University of Texas Southwestern Medical Center
Relevant relationships: None
Tracy Fausnight, MD FAAAAI
Penn State Children's Hospital/MSHMC
Relevant relationships: None
Rachel Glick Robison, MD FAAAAI
Vanderbilt University Medical Center
Relevant relationships: None
Marion E. Groetch, MS RDN
Icahn School of Medicine at Mount Sinai, New York, NY
Relevant relationships: None
Kathleen Hathaway, RN
Memorial Healthcare System/Joe DiMaggio Children's Hospital
Relevant relationships: None
Tamara Hubbard, MA LCPC
The Food Allergy Counselor, Inc. & Tamara Hubbard, LCPC, LLC
Relevant relationships: None
Stephanie Albin Leeds, MD FAAAAI
Yale School of Medicine
Relevant relationships: None
Michael Pistiner, MD MMSc
MassGeneral Hospital for Children, Food Allergy Center
Relevant relationships: A-Immune, Anjo, Bryn, FoodGraph (advisory board); Kaleo, Novartis (consultant)
Jennifer Protudjer, PhD FAAAAI
University of Manitoba
Relevant relationships: None
Nancy Rotter, PhD
Massachusetts General Hospital
Relevant relationships: None
Elisabeth Stieb, RN BSN AE-C
Massachusetts General Hospital
Relevant relationships: None
Elisa Thompson, NP
Oklahoma Allergy & Asthma Clinic
Relevant relationships: None
Carina Venter, PhD RD
University of Colorado/Children's Hospital Colorado
Relevant relationships: None
Richard Wasserman, MD PhD FAAAAI
Allergy Partners of North Texas
Relevant relationships: First Thought, Antheneum (consultant); Guidepoint Global (investment advisor); Cour Pharmaceuticals (research grant)
Content Reviewers:
Aikaterini Anagnostou, MD MSc PhD FAAAAI
Baylor College of Medicine
Relevant relationships: None
Jeffrey Chambliss, MD FAAAAI
University of Texas Southwestern, Dallas, TX
Relevant relationships: Novartis (consultant)
Amanda Louise Cox, MD FAAAAI
Icahn School of Medicine at Mount Sinai
Relevant relationships: None
Lauren Herlihy, DNP CPNP-CP
UNC Chapel Hill
Relevant relationships: None
Lois A. Nelson, MD FAAAAI
Lois A. Nelson MD LLC, Toledo, OH
Relevant relationships: None
Brian Vickery, MD FAAAAI
Emory University
Relevant relationships: Aimmune Therapeutics, Aravax, DBV Technologies (research grant); Allakos, Genetech (consultant)
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment: Name of employer and job title.
- Financial interests: All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests: All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts: All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
- Other interests: All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 2.25 Contact Hours.
Credit Claiming Period (Enduring)
Credit claiming for this activity will expire at 11:59 pm on January 30, 2027. Requests to claim credit on or after January 31, 2027 will be denied.
Medium and Method of Physician Participation for an Enduring Activity
Follow these steps to complete the activity:
- Register for the activity.
- Review the CME and Disclosure information.
- Complete all components that are of interest to you.
- Complete the post-test.
- Complete the activity evaluation.
- Claim your credits. Enter only the number of credits earned based on your participation in the activity. (30 min of activity = 0.50 CME credits)
- View/Print/Download your certificate.
The AAAAI reports earned CME/MOC credits to the ABAI on a quarterly basis.
Completions are reported on the schedule below:
| Date of course completion: | Date sent to ABAI |
| 1st Quarter (January 1 – March 31) | Reported by April 15 |
| 2nd Quarter (April 1 – June 30) | Reported by July 15 |
| 3rd Quarter (July 1 – September 30) | Reported by October 15 |
| 4th Quarter (October 1 – December 31) | Reported by January 15 |
Available Credit
- 2.25 AttendanceAttendance credit.
- 2.25 CECE credit.
- 2.25 CMECME credit.